Moody’s assigns ‘Baa’ rating to Presence Health’s bonds

Moody’s Investors Service has assigned a “Baa3” rating to Chicago-based Presence Health’s proposed series 2016C revenue bonds and affirmed Presence’s “Baa3” issuer rating.

Advertisement

The rating assignment and affirmation are based on several factors, including Moody’s Investors Service’s expectation that Presence Health’s cash flow challenges in fiscal years 2016 and 2017 will result in liquidity contraction.

The outlook is negative, reflecting Presence Health’s ongoing operating pressure, which could materially weaken its balance sheet.

More articles on healthcare finance:
Oregon price report explains payer exodus from some counties
Slowing U.S. healthcare wage growth sparks inflation concerns
Anthem Blue Cross of Calif. to launch bundled payment program for cancer care

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.